Anika Therapeutics, Inc. Settlement Liabilities, Current
Anika Therapeutics, Inc. (ANIK) had Settlement Liabilities, Current of $3.25 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:SettlementLiabilitiesCurrent · last filed 2023-05-09
- 2023-03-31: Settlement Liabilities, Current $3.25M.
- 2022-12-31: Settlement Liabilities, Current $0.00.
| Period end | Settlement Liabilities, Current |
|---|---|
| 2023-03-31 | $3.25M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $0.00 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |